Urology · Gahanna, OH
NPI
1609893221
Since 2006
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
701 Tech Center Dr
Gahanna, OH, 43230
Phone (614) 396-2684
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
13,737 services
Medicare patients, 2024
599
Average age 75
Drug cost, 2024
$6.9M
3,264 prescriptions
Company payments, 2025
$32K
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Benjamin J Martin was code J0897 (injection, denosumab, 1 mg), 5,220 times for 36 patients. In total Benjamin J Martin billed 13,737 services in 113 codes, and Medicare paid $1.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-02-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 5,220 | 36 | $20.59 | $107K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 4,200 | 40 | $0.10 | $429 |
| 99214 Office E&M - Established | Office | 462 | 297 | $85.24 | $39K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 458 | 53 | $44.92 | $21K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 449 | 63 | $140.46 | $63K |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 252 | 30 | $42.96 | $11K |
| 36415 Venipuncture Blood Collection | Office | 229 | 157 | $8.59 | $1,967 |
| 84153 Clinical Chemistry | Office | 215 | 130 | $17.88 | $3,843 |
| 99213 Office E&M - Established | Office | 98 | 92 | $56.53 | $5,540 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 94 | 69 | $12.35 | $1,161 |
| 96402 Chemotherapy Administration | Office | 77 | 64 | $23.46 | $1,806 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 72 | 32 | $34.88 | $2,511 |
| 84403 Clinical Chemistry | Office | 67 | 53 | $24.63 | $1,650 |
| 99212 Office E&M - Established | Office | 63 | 60 | $37.33 | $2,352 |
| 96372 Injection Administration | Office | 59 | 37 | $10.43 | $616 |
By year: 2022 $1.1M for 11,945 services; 2023 $1.1M for 12,410 services; 2024 $1.2M for 13,737 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 229 | 157 | $8.59 | $1,967 |
| 84153 Clinical Chemistry | 215 | 130 | $17.88 | $3,843 |
| 84403 Clinical Chemistry | 67 | 53 | $24.63 | $1,650 |
| 81003 Clinical Chemistry | 32 | 29 | $2.20 | $70.4 |
| 84402 Clinical Chemistry | 15 | 13 | $24.96 | $374 |
| G0416 Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 15 | 15 | $136.57 | $2,049 |
Medicare prescription drug claims, 2024
In 2024, the drug Benjamin J Martin prescribed most often to Medicare patients was Prednisone, with 650 prescriptions and refills. In total Benjamin J Martin wrote 3,264 Medicare prescriptions that cost $6.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 650 | 682 | 85 | $2,176 |
| Abiraterone Acetate Generic | 627 | 643 | 77 | $1.2M |
| Orgovyx Relugolix | 330 | 338 | 48 | $888K |
| Finasteride Generic | 234 | 692 | 89 | $3,345 |
| Tamsulosin Hcl Generic | 199 | 572 | 78 | $4,131 |
| Nubeqa Darolutamide | 183 | 189 | 26 | $2.3M |
| Alfuzosin Hcl Er Alfuzosin Hcl | 154 | 448 | 64 | $3,100 |
| Xtandi Enzalutamide | 135 | 135 | 15 | $1.4M |
| Erleada Apalutamide | 62 | 62 | Under 11 | $620K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 54 | 131 | 26 | $1,596 |
| Cephalexin Generic | 40 | 44 | 36 | $359 |
| Oxybutynin Chloride Generic | 38 | 59 | 15 | $335 |
| Gemtesa Vibegron | 34 | 50 | Under 11 | $23K |
| Methenamine Hippurate Generic | 28 | 53 | 12 | $2,266 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 28 | 28 | 27 | $85.77 |
Brand drugs: - claims; generic drugs: 2,416 claims; opioid claims: 52.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Benjamin J Martin $32K ($26K in general payments such as food, travel and fees and $5,131 for research) from 28 companies. The largest payer was Dendreon Pharmaceuticals LLC with $19K.
| Company | Payments | Amount |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 32 | $19K |
| Novartis Pharmaceuticals Corporation NVS | 11 | $3,440 |
| Ferring Pharmaceuticals Inc. | 10 | $3,175 |
| Janssen Biotech, Inc. JNJ | 16 | $2,412 |
| Avyxa Pharma, LLC | 1 | $1,000 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $918 |
| Janssen Global Services, LLC JNJ | 1 | $500 |
| AngioDynamics, Inc. ANGO | 2 | $301 |
| Immunitybio, Inc. IBRX | 5 | $264 |
| Sumitomo Pharma America, Inc. 4506.T | 14 | $241 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.